![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Alcyone Lifesciences and DNAtrix to Collaborate on Unique Delivery System to Treat Brain Tumors
Alcyone Lifesciences and DNAtrix to Collaborate on Unique Delivery System to Treat Brain Tumors
March 21, 2013
Alcyone Lifesciences, a privately held biopharmaceutical medical device company focusing on developing products for the treatment of difficult neuropathological conditions, and DNAtrix, a privately held biotechnology company developing virus-based immunotherapy products for cancer, today announced a collaboration to investigate Alcyone's Microcatheter System for delivery of therapeutics for brain tumor.
MarketWire
MarketWire
Upcoming Events
-
21Oct